Garden State Investment Advisory Services’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Garden State Investment Advisory Services’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,645	Closed	-$565K	–	243
2023 Q1	$565K	Buy	21,645 +3,740	+21%	+$100K	0.24%	77
2022 Q4	$491K	Buy	+17,905	New	+$476K	0.29%	74

Other funds holding FTXH

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

KNW

Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return

PPWM

Paragon Private Wealth Management Lexington, Kentucky $320M AUM 23.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Garden State Investment Advisory Services's FTXH Position: Q2 2023 in Review

Garden State Investment Advisory Services sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2023, closing a stake of 21,645 shares — an estimated $565K sold.

Garden State Investment Advisory Services first reported a position in FTXH in Q4 2022 and held it in 2 quarters. The position peaked at $565K in Q1 2023. 25 funds tracked by Wall St. Rank hold FTXH as of Q2 2023.

Garden State Investment Advisory Services reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
Garden State Investment Advisory Services sold 21,645 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2023, an estimated $565K.
Garden State Investment Advisory Services first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2022 and held it in 2 quarters.
Garden State Investment Advisory Services's First Trust Nasdaq Pharmaceuticals ETF position peaked at $565K in Q1 2023.
25 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2023.

Based on Garden State Investment Advisory Services's 13F filing for Q2 2023, filed 14 Aug 2023.